Search

EHT0202 in Alzheimers Disease: A 3-Month, Randomized, Placebo- Controlled, Double-Blind Study

Journal: Current Alzheimer Research
Volume: 8 Issue: 2 Year: 2011 Page: 203-212
Author(s): B. Vellas, O. Sol, P. J. Snyder, P.-J. Ousset, R. Haddad, M. Maurin, J.-C. Lemarie, L. Desire, M. P. Pando

Combination Treatment in Alzheimers Disease: Results of a Randomized, Controlled Trial with Cerebrolysin and Donepezil

Journal: Current Alzheimer Research
Volume: 8 Issue: 5 Year: 2011 Page: 583-591
Author(s): X. A. Alvarez, R. Cacabelos, C. Sampedro, V. Couceiro, M. Aleixandre, M. Vargas, C. Linares, E. Granizo, M. Garcia-Fantini, W. Baurecht, E. Doppler, H. Moessler

Atorvastatin Therapy Lowers Circulating Cholesterol but not Free Radical Activity in Advance of Identifiable Clinical Benefit in the Treatment of Mild-to-Moderate AD

Journal: Current Alzheimer Research
Volume: 2 Issue: 3 Year: 2005 Page: 343-353
Author(s): D. Larry Sparks, Marwan N. Sabbagh, Donald J. Connor, Jean Lopez, Lenore J. Launer, Suzana Petanceska, Patrick Browne, Dawn Wassar, Sherry Johnson-Traver, Jeff Lochhead

Impact of COVID-19 Mandatory Lockdown Measures on Cognitive and Neuropsychiatric Symptoms in Persons with Alzheimer's Disease in Lima,Peru

Journal: Current Alzheimer Research
Volume: 20 Issue: 2 Year: 2023 Page: 80-88
Author(s): Juan C. Carbajal,Monica M. Diaz

How Should We Deal with Missing Data in Clinical Trials Involving Alzheimers Disease Patients?

Journal: Current Alzheimer Research
Volume: 8 Issue: 4 Year: 2011 Page: 421-433
Author(s): N. Coley, V. Gardette, C. Cantet, S. Gillette-Guyonnet, F. Nourhashemi, B. Vellas, S. Andrieu

Efficacy of Transcranial Direct Current Stimulation Combined with Cognitive Training in the Treatment of Apathy in Patients with Alzheimer’s Disease: Study Protocol for a Randomized Trial

Journal: Reviews on Recent Clinical Trials
Volume: 13 Issue: 4 Year: 2018 Page: 319-327
Author(s): Jean-Paul Nguyen,Claire Boutoleau-Bretonniere,Jean-Pascal Lefaucheur,Alcira Suarez,Helene Gaillard,Guillaume Chapelet,Sebastien Abad,Aurelien Van Langhenhove,Julian Nizard,Laure de Decker

Current Quest in Natural Bioactive Compounds for Alzheimer’s Disease: Multi-Targeted-Designed-Ligand Based Approach with Preclinical and Clinical Based Evidence

Journal: Current Drug Targets
Volume: 22 Issue: 6 Year: 2021 Page: 685-720
Author(s): Ashif Iqubal,Syed Obaidur Rahman,Musheer Ahmed,Pratichi Bansal,Md Rafi Haider,Mohammad Kashif Iqubal,Abul Kalam Najmi,Faheem Hyder Pottoo,Syed Ehtaishamul Haque

Journal: Current Alzheimer Research
Volume: 12 Issue: 1 Year: 2015 Page: 53-60
Author(s): George T. Grossberg, Martin R. Farlow, Xiangyi Meng, Drew M. Velting

Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial

Journal: Current Alzheimer Research
Volume: 5 Issue: 1 Year: 2008 Page: 83-89
Author(s): Anton P. Porsteinsson, George T. Grossberg, Jacobo Mintzer, Jason T. Olin

Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer’s Disease: Results from a Double-Blind, Placebo-Controlled Trial

Journal: Current Alzheimer Research
Volume: 14 Issue: 4 Year: 2017 Page: 403-411
Author(s): Boris Decourt,Denise Drumm-Gurnee,Jeffrey Wilson,Sandra Jacobson,Christine Belden,Sherye Sirrel,Michael Ahmadi,Holly Shill,Jessica Powell,Aaron Walker,Amanda Gonzales,Mimi Macias,Marwan N. Sabbagh